Exact Sciences Corp.

Exact Sciences Corp.
	Innovation One, the headquarters of Exact Sciences in Madison, Wisconsin (2020).
Company type	Public
Traded as	Nasdaq: EXAS; Russell 1000 component;
Industry	Molecular diagnostics
Founded	1995 in Marlborough, Massachusetts
Founders	Stanley Lapidus; Anthony P. Shuber;
Headquarters	Madison, Wisconsin, U.S.
Key people	Kevin Conroy (chairman, president & CEO); Jorge Garces (CSO);
Products	Cologuard, Oncotype DX, Oncotype MAP
Revenue	US$2.50 billion (2023)
Operating income	US$−215 million (2023)
Net income	US$−204 million (2023)
Total assets	US$6.47 billion (2023)
Total equity	US$3.15 billion (2023)
Number of employees	6,500 (Dec 2023)
Subsidiaries	Subsidiary List Biomatrica; Exact Sciences Development; Exact Sciences Innovation; Exact Sciences International; Exact Sciences Laboratories; Exact Sciences Thrive; Genomic Health; Paradigm Diagnostics; Prevention Genetics;
Website	exactsciences.com
	Footnotes / references;

Exact Sciences Corp. is an American molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer. Since then Exact Sciences has grown its product portfolio to encompass other screening and precision oncological tests for other types of cancer.